Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

June
10
2019

Sensus Healthcare to Present at the Raymond James Inaugural Life Sciences and MedTech Conference

BOCA RATON, Fla., June 10, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of…

May
15
2019

Sensus Healthcare to Present at the 20th Annual B. Riley FBR Investor Conference

BOCA RATON, Fla., May 15, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of…

May
09
2019

Sensus Healthcare Reports First Quarter 2019 Financial Results

– Premier, Inc. adds SRT to its group purchasing contracts – Ships second Sculptura™ system to Rabin Medical Center in Israel – Reaffirms expectations for double-digit full-year revenue growth – Conference call begins at 4:30…

May
08
2019

Sensus Healthcare Awarded Brachytherapy Products Agreement with Premier

BOCA RATON, Fla., May 8, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in novel radiation oncology technologies and solutions, has been awarded a group purchasing agreement for Brachytherapy Products with…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy